BRCA1 and RAD51C promoter hypermethylation confer sensitivity to the PARP inhibitor rucaparib in patients with relapsed, platinum-sensitive ovarian carcinoma in ARIEL2 Part 1
| Autor: | Swisher, E.M., Harrell, M.I., Lin, K., Coleman, R.L., Konecny, G.E., Tinker, A.V., O'Malley, D.M., McNeish, I., Kaufmann, S.H. |
|---|---|
| Zdroj: | In Gynecologic Oncology June 2017 145 Supplement 1:5-5 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect